Trust Investment Advisors Sells 2,528 Shares of Celestica Inc. (NYSE:CLS)

Trust Investment Advisors lessened its holdings in Celestica Inc. (NYSE:CLSFree Report) (TSE:CLS) by 10.5% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 21,467 shares of the technology company’s stock after selling 2,528 shares during the period. Celestica makes up 1.3% of Trust Investment Advisors’ portfolio, making the stock its 19th biggest position. Trust Investment Advisors’ holdings in Celestica were worth $1,981,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in CLS. Peregrine Capital Management LLC acquired a new position in Celestica in the fourth quarter worth about $30,000. Private Trust Co. NA raised its holdings in shares of Celestica by 480.0% in the 3rd quarter. Private Trust Co. NA now owns 870 shares of the technology company’s stock worth $44,000 after buying an additional 720 shares in the last quarter. R Squared Ltd bought a new position in shares of Celestica during the 4th quarter worth approximately $51,000. IFP Advisors Inc boosted its stake in Celestica by 122.7% in the 4th quarter. IFP Advisors Inc now owns 668 shares of the technology company’s stock valued at $62,000 after buying an additional 368 shares in the last quarter. Finally, UMB Bank n.a. grew its position in Celestica by 43.6% in the fourth quarter. UMB Bank n.a. now owns 949 shares of the technology company’s stock valued at $88,000 after acquiring an additional 288 shares during the period. Institutional investors and hedge funds own 67.38% of the company’s stock.

Celestica Trading Down 2.6 %

CLS stock opened at $97.37 on Wednesday. The company has a quick ratio of 0.87, a current ratio of 1.47 and a debt-to-equity ratio of 0.49. Celestica Inc. has a twelve month low of $40.25 and a twelve month high of $144.27. The company has a market cap of $11.29 billion, a P/E ratio of 26.03 and a beta of 2.21. The business has a fifty day moving average of $109.73 and a 200-day moving average of $87.11.

Insider Buying and Selling

In other Celestica news, CEO Robert Mionis sold 75,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $141.29, for a total value of $10,596,750.00. Following the transaction, the chief executive officer now directly owns 456,417 shares of the company’s stock, valued at approximately $64,487,157.93. This trade represents a 14.11 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Alok K. Agrawal sold 6,826 shares of the company’s stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $133.92, for a total transaction of $914,137.92. Following the sale, the insider now owns 9,224 shares of the company’s stock, valued at $1,235,278.08. The trade was a 42.53 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 959,381 shares of company stock worth $119,142,019 over the last three months. 1.00% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Canaccord Genuity Group lifted their price objective on Celestica from $77.00 to $110.00 and gave the company a “buy” rating in a report on Friday, December 20th. JPMorgan Chase & Co. initiated coverage on shares of Celestica in a research report on Friday, February 21st. They issued an “overweight” rating and a $166.00 price target on the stock. CIBC raised shares of Celestica from a “neutral” rating to a “sector outperform” rating and set a $150.00 price objective for the company in a report on Friday, January 31st. Royal Bank of Canada lifted their target price on shares of Celestica from $115.00 to $140.00 and gave the company an “outperform” rating in a research note on Friday, January 31st. Finally, Barclays increased their price target on Celestica from $139.00 to $157.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Two analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Celestica has an average rating of “Moderate Buy” and a consensus target price of $110.83.

View Our Latest Report on CLS

Celestica Profile

(Free Report)

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.

Featured Stories

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica Inc. (NYSE:CLSFree Report) (TSE:CLS).

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.